bool(false)

COVAX vaccines will no longer need regulatory clearance in Brazil

. Feb 09, 2021
COVAX vaccines will no longer need regulatory clearance in Brazil Photo: Myboys.me/Shutterstock

Brazilian health regulator Anvisa will no longer require vaccines used by the UN-backed COVAX facility to file requests for emergency approval. Brazil is expected to receive 10.6 million of the 42 million doses it is entitled to in the first half of the year, mainly from AstraZeneca.

The decision may help speed up the immunization process, as India’s Serum Institute — which has provided the first 2 million doses of the AstraZeneca vaccine — would otherwise have to file for emergency use requests in Brazil.

Support this coverage →Support this coverage →
 
Natália Scalzaretto

Natália Scalzaretto has worked for companies such as Santander Brasil and Reuters, where she covered news ranging from commodities to technology. Before joining The Brazilian Report, she worked as an editor for Trading News, the information division from the TradersClub investor community.

Our content is protected by copyright. Want to republish The Brazilian Report? Email us at contact@brazilian.report